Xevudy, Konzentrat zur Herstellung einer Infusionslösung
7680684710018
CH-68471
Konzentrat
Associated product:
XEVUDY conc perf 500 mg/8ml flac 8 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
sotrovimabum
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
saccharum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
methioninum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 68471
- Drug name
- Xevudy, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- J06BD05
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- A
- First authorization
- 14/01/2022
- Authorization expiration date
- 13/11/2025
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- XEVUDY conc perf 500 mg/8ml flac 8 ml
- Description (DE)
- XEVUDY Inf Konz 500 mg/8ml Durchstf 8 ml
- Market launch
- 14/01/2022
- Market withdrawal
- 29/08/2024
- Narcotic (BTM)
- No